Skip to main content

Taro Pharmaceuticals Case 08/02/2004

  • If you purchased a significant amount of shares of this company you have certain options and for certain investors are short and strict deadlines running. Investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

<p>On Monday, April 28th, Taro Pharmaceuticals Ltd. announced, the same day a federal judge in the U.S. District Court for the Southern District of New York refused the company’s motion to dismiss the purported shareholder class action, that it had reached a settlement over a class action with the shareholders, who alleged the company that is sold excessive amounts of drugs in o...

You must register (for free) or login to view the entire case.